Growing Geriatric Population Is Driving the Listeria Monocytogenes Infections Treatment Market Growth

 

Listeria monocytogenes, is a gram positive, intracellular, facultative anaerobic, ubiquitous bacterium which causes infections known as listeriosis. Listeriosis spreads by consumption of contaminated food, such as cheeses, raw or unpasteurized milk, ready-to-eat meats, processed vegetables, foods, and smoked fish products. Listeria monocytogenes infection can lead to septicemia and meningitis. In people with weak immune system it can lead to HIV, diabetes, cancer, kidney, and liver disease. Moreover, listeriosis is a threat to pregnant women resulting in meningitis, premature delivery, and stillbirth in the infants leading to permanent disability.

Thus, there is an increasing demand for listeria monocytogenes infections treatment. According to the Centers for Disease Control and Prevention (CDC), every year, around 1,600 people are infected by listeriosis and 260 people die due to listeria monocytogenes infections. This in turn is expected to augment the listeria monocytogenes infections treatment market growth. The infection primarily occurs due to the ingestion of food contaminated with the bacterium.  Listeria monocytogenes infection is most likely to sicken people with the weakened immune systems, adults aged 65 or older, and pregnant women and their newborns. Pregnant women are ten times more likely to get listeria infection than other people.

Thus, with the increasing rate of pregnancy and the growing geriatric population worldwide, the demand for listeria monocytogenes infections treatment is also increasing. According to the World Health Organization (WHO), by 2050, the world's population aged 60 years and older is expected to total 2 billion, up from 900 million in 2015. This in turn is also expected to drive the listeria monocytogenes infections treatment market growth. Listeriosis leads to a variety of symptoms, such as fever, muscle ache, flu-like, stiff neck, balance loss, head ache, confusion, and convulsions. Other complications of listeriosis include meningoencephalitis, meningitis, and sepsis. There is an increasing demand for listeria monocytogenes infections treatment around the world due to the aforementioned factors.

In September 2020, PerkinElmer, Inc. launched the PerkinElmer Solus Listeria monocytogenes ELISA Assay or testing across food and environmental samples. It is being introduced with Performance Tested Method SM certification from AOAC INTERNATIONAL (Association of Official Analytical Collaboration). Moreover, listeria monocytogenes infections treatment market is driven by the increasing prevalence of foodborne infections. Increase in consumption of frozen food has increased the frequency of listeriosis. According to the CDCD, listeria is the third leading cause of death from foodborne illnesses. This in turn is also expected to boost the growth of the market over the forecast period.